November 30: The Department of Drug Administration (DDA) has cautioned the drug manufacturers and dealers not to sell and distribute pediatric drugs having chemical compounds such as Ethylene Glycol and Diethylene Glycol.    
According to the state-owned national news agency RSS, DDA's Senior Drug Manager Santosh KC issued a statement on Tuesday and warned the consumers towards possible mix-up of such hazardous chemicals in some liquid medicines used for children.    
According to the DDA, the World Health Organization (WHO)'s report has also noted that the use of medicines having Ethylene Glycol and Diethylene Glycol in different countries, including Zambia and Indonesia, has had serious effect on their kidneys of children and also caused death in some cases.    
In the statement, the department has made it clear that the medicines such as Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, My Cough Baby Cough Syrup and Magrip and Cold Syrup produced by Haryana-based Miden Pharmaceuticals Limited containing such hazardous substance have not been registered in Nepal.    
The department has also instructed the drug manufacturing companies to ensure that they do not mix-up of such harmful chemical elements in the drugs manufactured and sold in Nepal, added RSS.